MTOR and pancreatic neoplasm: Gemcitabine has been the standard treatment for advanced-stage pancreatic cancer since it inhibits cell proliferation and causes apoptosis of tumor cells through the activation of the adenosine monophosphate-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) pathway[17].